BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Händelser för Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241110
DTEND;VALUE=DATE:20241114
DTSTAMP:20260430T151448
CREATED:20241023T094214Z
LAST-MODIFIED:20241104T133521Z
UID:5547-1731196800-1731542399@abliva.com
SUMMARY:CNS Summit 2024
DESCRIPTION:Abliva kommer att delta i CNS Summit 2024\, som äger rum den 10-13 november på Encore Boston Harbor\, Boston (USA). \nFöretagets VD Ellen Donnelly har organiserat\, och kommer den 11 november kl 13:00 ET att delta i\, paneldiskussionen ”Medicines for Mito: Developing Medicines for Mitochondrial Dysfunction Spotlight Session”\, med representanter från Stealth-\, Tisento- och Saol Therapeutics. \nFölj länken nedan för mer information.
URL:https://abliva.com/sv/event/cns-summit-2024/
LOCATION:Encore Boston Harbor\, Boston\, MA\, United States
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/png:https://abliva.com/wp-content/uploads/2024/10/Medicines-for-Mito.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240626
DTEND;VALUE=DATE:20240630
DTSTAMP:20260430T151448
CREATED:20240402T134918Z
LAST-MODIFIED:20240402T134918Z
UID:5096-1719360000-1719705599@abliva.com
SUMMARY:Mito Med 2024
DESCRIPTION:I slutet av juni kommer Abliva att medverka vid den amerikanska patientorganisationen UMDS:s Mitochondrial Disease Conference i Cleveland\, Ohio. \n”Each year\, UMDF’s Mitochondrial Medicine Conference brings together the best minds in mitochondrial medicine and the patients we serve. With over 700 attendees representing almost every state in the U.S. and more than 15 different countries\, the Conference is recognized as the world’s preeminent event for mitochondrial disease.”. \nFölj länken nedan för mer information.
URL:https://abliva.com/sv/event/mito-med-2024/
LOCATION:Cleveland\, Ohio\, Cleveland\, OH\, United States
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2024/04/cleveland.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240521T160000
DTEND;TZID=Europe/Stockholm:20240521T170000
DTSTAMP:20260430T151448
CREATED:20240502T152707Z
LAST-MODIFIED:20240502T152707Z
UID:5206-1716307200-1716310800@abliva.com
SUMMARY:Virtuellt KOL-event om KL1333 (hålls på engelska)
DESCRIPTION:Join Abliva for a virtual KOL event featuring Amel Karaa\, MD (Massachusetts General Hospital)\, who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial disease. There are currently no approved medicines for the systemic disease. \nThe event will focus on Abliva’s lead program\, KL1333\, which has shown clinically meaningful\, early signals of efficacy in mitochondrial disease patients. This novel therapeutic approach modulates the underlying pathophysiology in mitochondrial disease. KL1333 is currently being evaluated in the pivotal Phase 2 FALCON trial\, with interim analysis expected mid-year 2024. KL1333 has Orphan Drug Designation (ODD) in both Europe and the U.S. and Fast Track designation in the U.S. \nRegistration information \nRegister here: https://lifescievents.com/event/abliva/\nA live question and answer session will follow the formal presentation. Ask your question to: questions@lifesciadvisors.com. \nYou are required to register in advance for the webcast. For those who are unable to attend live\, a replay will be available via the link below.
URL:https://abliva.com/sv/event/virtuellt-kol-event-om-kl1333-halls-pa-engelska/
CATEGORIES:Investerarevent,Vetenskapligt event
ATTACH;FMTTYPE=image/png:https://abliva.com/wp-content/uploads/2024/05/Abliva-Social-Media-v2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240318
DTEND;VALUE=DATE:20240321
DTSTAMP:20260430T151448
CREATED:20240122T100656Z
LAST-MODIFIED:20240318T085643Z
UID:4132-1710720000-1710979199@abliva.com
SUMMARY:Mitochondrial Medicine - Therapeutic Development
DESCRIPTION:I mitten av mars kommer Abliva att medverka vid den åttonde upplagan av konferensen Mitochondrial Medicine – Therapeutic Development i Hinxton\, Storbritannien. \nDetta årliga möte fokuserar på mitokondriell sjukdom och sökandet efter nya behandlingar. \nAblivas CMO\, Maguns Hansson\, kommer att delta I paneldiskussionen Challenges and opportunities in clinical trials: perspectives\nfrom pharma and funders där även representanter från andra bolag i fältet samt akademiska och kliniska experter medverkar. \nFölj länken nedan för mer information.
URL:https://abliva.com/sv/event/mitochondrial-medicine-therapeutic-development/
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2024/01/Magnus_Fia_kameraa-e1710752165285.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230919
DTEND;VALUE=DATE:20230920
DTSTAMP:20260430T151448
CREATED:20230919T112402Z
LAST-MODIFIED:20230919T112402Z
UID:3885-1695081600-1695167999@abliva.com
SUMMARY:Empower & Inspire - 2nd Annual Leigh Syndrome Symposium
DESCRIPTION:Under World Mitochondrial Disease Week\, kommer Ablivas Chief Medical Officer\, Magnus Hansson\, att presentera bolaget vid Cure Mito Foundation’s Empower & Inspire – 2nd Annual Leigh Syndrome Symposium (virtuellt). \nSe nedan för mer information och länken till eventet.
URL:https://abliva.com/sv/event/empower-inspire-2nd-annual-leigh-syndrome-symposium/
LOCATION:Virtual
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2023/09/LS-symposium-presenting.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230628
DTEND;VALUE=DATE:20230702
DTSTAMP:20260430T151448
CREATED:20230207T085441Z
LAST-MODIFIED:20230207T085544Z
UID:3552-1687910400-1688255999@abliva.com
SUMMARY:UMDF:s Mitochondrial Medicine Symposium 2023
DESCRIPTION:I slutet av juni kommer Abliva att medverka vid årets internationella konferens Mitochondrial Medicine Symposium 2023\, arrangerad av amerikanska patientorganisationen United Mitochondrial Disease Foundation. \nMötet kommer att hållas i Charlotte\, North Carolina (USA) den 28 juni – 1 juli\, och inkluderar både vetenskapliga och patient/familj-sessioner.
URL:https://abliva.com/sv/event/umdfs-mitochondrial-medicine-symposium-2023/
LOCATION:Sheraton Charlotte Hotel/Le Méridien\, 555 SOUTH MCDOWELL STREET\, Charlotte\, NC\, 28204\, United States
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2023/02/charlotte_NC_US.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230611
DTEND;VALUE=DATE:20230616
DTSTAMP:20260430T151448
CREATED:20230116T103551Z
LAST-MODIFIED:20230116T103551Z
UID:3502-1686441600-1686873599@abliva.com
SUMMARY:Euromit 2023
DESCRIPTION:I juni deltar Abliva i årets upplaga av Euromit – den internationella konferensen om mitokondriell sjukdom. \nMötet äger rum i Bologna\, Italien\, och samlar forskare\, kliniker och patienter för att dela kunskaper och insikter inom området. Konferensen innebär också en möjlighet att träffa prövare i vår FALCON–studie med KL1333.
URL:https://abliva.com/sv/event/euromit-2023-2/
LOCATION:Bologna Congress Center\, Piazza della Costituzione\, 4/a\, Bologna\, Italy
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2023/01/bologna.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221121
DTEND;VALUE=DATE:20221124
DTSTAMP:20260430T151448
CREATED:20221114T101601Z
LAST-MODIFIED:20221122T084434Z
UID:3415-1668988800-1669247999@abliva.com
SUMMARY:Mitochondrial Medicine - Therapeutic Development
DESCRIPTION:I slutet på november deltar Abliva vid den årliga vetenskapliga konferensen Mitochondrial Medicine – Therapeutic Development i Hinxton\, Storbritannien. \nAblivas medicinska chef Magnus Hansson kommer att presentera en poster som tar upp resultaten från en av de viktiga förberedande studierna inför FALCON-studien\, den kommande kliniska\, potentiellt registreringsgrundande\, fas 2-studien med KL1333 i patienter med mitokondriella sjukdomar. \n 
URL:https://abliva.com/sv/event/mitochondrial-medicine-therapeutic-development-4/
LOCATION:Wellcome Genome Campus\, Hinxton\, United Kingdom
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2020/10/Magnus_whiteboard.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221007
DTEND;VALUE=DATE:20221009
DTSTAMP:20260430T151448
CREATED:20220816T124023Z
LAST-MODIFIED:20221004T113646Z
UID:3316-1665100800-1665273599@abliva.com
SUMMARY:Mitocons Mitochondrial Diseases Conference
DESCRIPTION:I oktober medverkar Abliva vid den italienska patientorganisationen Mitocons konferens Mitochondrial Diseases Conference i Rom\, Italien. \nDen 8 oktober kommer Ablivas medicinska chef Magnus Hansson att ge en presentation med titeln: En adaptiv klinisk fas 2/3-studie som utvärderar effekten av KL1333 i vuxna patienter med primär mitokondriell sjukdom under Session 5: Challenges and pitfalls in clinical trials design – presentations and round table discussion.
URL:https://abliva.com/sv/event/mitocons-mitochondrial-diseases-conference-2/
LOCATION:Holiday Inn Rome EUR Parco dei Medici\, Rome\, Italy
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/08/Rome_Colosseo.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220915
DTEND;VALUE=DATE:20220918
DTSTAMP:20260430T151448
CREATED:20220815T141759Z
LAST-MODIFIED:20220815T141759Z
UID:3305-1663200000-1663459199@abliva.com
SUMMARY:mitoNice
DESCRIPTION:I september kommer Abliva att delta i mitoNice\, en internationell kongress tillägnad mitokondriell medicin.
URL:https://abliva.com/sv/event/mitonice-2/
LOCATION:Nice Acropolis Congress Center\, Nice\, France
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/08/Nice_France.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220629
DTEND;VALUE=DATE:20220701
DTSTAMP:20260430T151448
CREATED:20220621T124158Z
LAST-MODIFIED:20220621T124158Z
UID:3267-1656460800-1656633599@abliva.com
SUMMARY:Bioblast 2022: Inaugural Conference of Bioenergetics Communications
DESCRIPTION:Den 29-30 juni deltar Abliva i Bioblast 2022: Inaugural Conference of Bioenergetics Communications i Innsbruck\, Österrike. \nAblivas Kommunikatör & laboratoriechef Eleonor Åsander Frostner kommer att presentera en sammanfattning av bolagets nyligen publicerade preprint-artikel ”Towards a treatment for mitochondrial disease: current compounds in clinical development”.
URL:https://abliva.com/sv/event/bioblast-2022-inaugural-conference-of-bioenergetics-communications-2/
LOCATION:Congress Innsbruck\, Rennweg 3\, Innsbruck\, Austria
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/06/Innsbruck.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220608
DTEND;VALUE=DATE:20220612
DTSTAMP:20260430T151448
CREATED:20220608T114604Z
LAST-MODIFIED:20220608T114604Z
UID:3248-1654646400-1654991999@abliva.com
SUMMARY:UMDF:s Mitochondrial Medicine Symposium
DESCRIPTION:Abliva medverkar vid United Mitochondrial Disease Foundations Mitochondrial Medicine Symposium i Phoenix\, Arizona\, USA. \nAblivas medicinska chef Magnus Hansson kommer att medverka i en paneldiskussion om kliniska prövningar tillsammans med Baylor College of Medicine\, Cyclerion Therapeutics och Khondrion\, på fredag den 10 juni.
URL:https://abliva.com/sv/event/umdfs-mitochondrial-medicine-symposium-2/
LOCATION:JW Marriott Phoenix Desert Ridge Resort & Spa\, Phoenix\, AZ\, United States
CATEGORIES:Vetenskapligt event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2022/06/Phoenix_Arizona.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220222
DTEND;VALUE=DATE:20220225
DTSTAMP:20260430T151448
CREATED:20211129T085909Z
LAST-MODIFIED:20211129T085909Z
UID:2992-1645488000-1645747199@abliva.com
SUMMARY:Mitochondria-Targeted Drug Development Summit
DESCRIPTION:Abliva kommer att delta och presentera vid konferensen Mitochondria-Targeted Drug Development Summit i Boston\, MA\, USA. Eventet hålls den 22 – 24 februari 2022. \nVD Ellen Donnelly kommer att presentera under sessionen Patient-Focused Drug Development for Mitochondrial Disease. \nSynopsis: \n\nHighlighting the impact of patient input on research and development at Abliva\nProviding an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva\nPresenting placebo controlled PMD patient data from our lead asset\, KL1333
URL:https://abliva.com/sv/event/mitochondria-targeted-drug-development-summit-2/
LOCATION:Hyatt Regency Boston/Cambridge\, 575 Memorial Dr\, Cambridge\, Massachusetts\, 02139\, United States
CATEGORIES:Vetenskapligt event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211130
DTEND;VALUE=DATE:20211203
DTSTAMP:20260430T151448
CREATED:20211111T130848Z
LAST-MODIFIED:20211122T145613Z
UID:2972-1638230400-1638489599@abliva.com
SUMMARY:Mitochondrial Medicine - Therapeutic Development
DESCRIPTION:Abliva kommer att delta vid den virtuella konferensen Mitochondrial Medicine – Therapeutic Development\, arrangerad av Wellcome Connecting Science vid Wellcome Genome Campus i Storbritannien. Konferensen äger rum den 30 nov – 2 dec 2021. \nAblivas medicinska chef Magnus Hansson\, har blivit inbjuden att hålla en presentation i ämnet Academia-pharma interplay in drug development\, under Session 1: Mitochondrial Medicine – pharma and funding perspectives.
URL:https://abliva.com/sv/event/mitochondrial-medicine-therapeutic-development-2/
LOCATION:Virtual
CATEGORIES:Vetenskapligt event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210624
DTEND;VALUE=DATE:20210627
DTSTAMP:20260430T151448
CREATED:20210524T105444Z
LAST-MODIFIED:20210524T105444Z
UID:2778-1624492800-1624751999@abliva.com
SUMMARY:UMDF Mitochondrial Medicine
DESCRIPTION:Den amerikanska patientorganisationen United Mitochondrial Disease Foundation (UMDF) arrangerar sitt årliga Mitochondrial Medicine Symposium\, i år virtuellt\, i juni.  \nAbliva kommer att delta i de vetenskapliga delarna av symposiet: \n\nMagnus Hansson\, medicinsk chef\, kommer att utgöra en av paneldeltagarna fredagen den 25 juni klockan 13.50 EST\, i Clinical Trials Panel #2 Discussion\, tillsammans med representanter från Baylor College of Medicine\, Cyclerion Therapeutics och Khondrion.\nData från Ablivas fas 1a/b-studie med KL1333 kommer att presenteras på en vetenskaplig e-Poster\, tillgänglig för registrerade deltagare under hela evenemanget.
URL:https://abliva.com/sv/event/umdf-mitochondrial-medicine-2/
LOCATION:Virtual
CATEGORIES:Vetenskapligt event
END:VEVENT
END:VCALENDAR